Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Microbial
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(38)
1 / 2
Gut-Brain Axis
The Gut–Brain Axis and the Future of Microbiome-Directed Mental Health Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-22
May 25, 2026
NGIB
Rethinking Fermentation: Halophiles and the Next Generation of Industrial Biotechnology
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-05
May 18, 2026
Microbiome
Zymo Research Launches Fecal Microbiome Discovery Grant to Enable the Next Breakthroughs in Human Health
Zymo Research Corp.
PR-04-26-10
Apr 24, 2026
Antibiotics R&D
The Rebirth of Antibiotic R&D: New Momentum for an Old Crisis
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-25-NI-05
Dec 10, 2025
Partnerships
Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing
Ajinomoto Bio-Pharma Services
PR-10-25-NI-19
Oct 28, 2025
Biologics
HIPRA Biotech Services' End-to-End Biologics Offering
HIPRA Biotech Services
PAO-08-25-BIO-07
Sep 3, 2025
Oncology
Engineered Bacteria as Precision Therapeutics for Cancer and Beyond
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-09
Jun 23, 2025
Fermentation
Achieving Scalable and Sustainable Precision Fermentation Using Process Analytical Technology
Charlotte Hughes, Ph.D.
Hamilton Company
PAO-02-25-CL-18
Feb 27, 2025
CDMO
Navigating the Complexities of Microbial and Mammalian Manufacturing
Peter Boman; Helena Pettersson
NorthX Biologics
PAO-12-24-CL-3
Jan 2, 2025
Technology
Building the Future of E. coli Biomanufacturing with Protein Secretion
Trond Erik Vee Aune, Ph.D.; Dominik Bahiense de Mello; Jostein Malmo, Ph.D.
Vectron Biosolutions
PAO-11-24-CL-07
Nov 18, 2024
Biotherapeutics
Building on Australia's Existing Biopharma Infrastructure
BioCina
PAO-11-24-RTM-07
Nov 15, 2024
Financing
Microbiologics Acquires SensID, Expanding Expertise in Diagnostic Quality Controls
Microbiologics
PR-10-24-NI-76
Nov 6, 2024
Lead Share Agreement
List Biotherapeutics and Sacco System Announce Lead Share Agreement
List Biotherapeutics
PR-M03-24-03
Mar 14, 2024
Biotherapeutics
Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO
John R. Mosack
Tanvex CDMO
PAO-10-23-CL-05
Nov 7, 2023
Plasmid Manufacturing
Optimizing Plasmid Production to Meet Growing Demand
Danielle Alvarez; Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-04-23-NI-01
Apr 3, 2023
Biomanufacturing
On the Journey to a New Industry Standard for E. coli-based Protein Production
Trond Erik Vee Aune, Ph.D.; Jostein Malmo, Ph.D.; Dominik Bahiense de Mello
Vectron Biosolutions
PAO-03-23-CL-03
Mar 15, 2023
Patented Production Strains
Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains
Trond Erik Vee Aune, Ph.D.
Vectron Biosolutions
PAO-08-022-CL-03
Aug 16, 2022
Biomanufacturing
The Smart Approach to Preclinical Development for Bacterially Expressed Biologics
Trond Erik Vee Aune, Ph.D.
Vectron Biosolutions
PAO-04-022-CL-13
Apr 28, 2022
Biomanufacturing
Unique Vector Expression Technologies for Boosting Protein Production in E. coli
Trond Erik Vee Aune, Ph.D.
Vectron Biosolutions
PAO-02-022-CL-16
Mar 20, 2022
Automation
Innovating in Automation and Data Management to Advance Microbiology
Lonza
PAO-03-22-R250-06
Mar 7, 2022
1 / 2